This inventor holds 3 USPTO granted patents. Top assignee: Oregon Health & Science University. Active years: 2000-2002.
Location History:
- Newton, MA (US) (2001)
- Portland, OR (US) (2000 - 2002)
Company Filing History:
Years Active: 2000-2002
Title: Innovations of Wenbiao Chen in Melanocortin Receptor Research
Introduction
Wenbiao Chen is a prominent inventor based in Portland, OR (US). He has made significant contributions to the field of biochemistry, particularly in the study of melanocortin receptors. With a total of 3 patents, his work focuses on developing methods and reagents that can modulate feeding behavior and treat various disorders.
Latest Patents
Wenbiao Chen's latest patents include innovative methods and reagents for discovering and utilizing mammalian melanocortin receptor agonists and antagonists. One of his notable inventions provides recombinant expression constructs that encode mammalian melanocortin receptors. This invention allows for the creation of mammalian cells that express functional melanocortin receptors, which can be used to screen compounds for receptor activity. Another significant patent involves developing naturally-occurring and synthetic agonists and antagonists specific for the MC5-R receptor. This invention aims to treat and alleviate dysfunctions related to thermoregulatory disorders and other gland-related diseases.
Career Highlights
Wenbiao Chen is affiliated with Oregon Health & Science University, where he conducts his research. His work has been instrumental in advancing the understanding of melanocortin receptors and their implications in metabolic and behavioral modifications.
Collaborations
Wenbiao Chen has collaborated with notable colleagues, including Roger D. Cone and Wei Fan, to further his research endeavors. Their combined expertise has contributed to the development of innovative solutions in the field.
Conclusion
Wenbiao Chen's contributions to the field of melanocortin receptor research highlight his innovative spirit and dedication to advancing scientific knowledge. His patents reflect a commitment to addressing critical health issues through biochemistry and molecular biology.